Mylynda Massart, MD, PhD
Associate Professor, Molecular Biologist
University of Pittsburgh
The Future of Multi-Cancer Early Detection
To close this series, experts explore the challenges and guideline gaps in multi-cancer early detection while considering its potential impact on patient care, accessibility, and improved outcomes.
Optimizing Patient Pathways in Multi-Cancer Detection
Experts explore strategies for efficient patient care coordination through early cancer detection, highlighting cost challenges while ensuring timely diagnoses and treatments.
Understanding BBS: Interpreting and Responding to Results
Mylynda Massart, MD, PhD, nuances of blood-based screening (BBS) in early cancer detection and how doctors can respond to various results.
Clinical Implementation of Cancer Screening Strategies
Experts delve into the complexities of cancer screening, from identifying high-risk individuals to counseling patients about the nuances of screening tests, all while aiming for early detection and improved outcomes.
Navigating the Transition to Precision Medicine in Early Cancer Detection
Experts discuss the transition from evidence-based medicine to precision medicine in the context of cancer screening, emphasizing the urgency of implementing multi-cancer screening for broad positive outcomes.
Landscape of Multi-Cancer Early Detection Tests
Experts discuss the evolving landscape of multicancer early detection tests, including those in development and currently available.
Multi-Cancer Detection: Transforming Screening
Experts discuss the emerging landscape of multicancer early detection testing through liquid biopsy, highlighting its potential to revolutionize cancer screening.
Guidelines and Inequities: Insights from Experts
Candace Westgate, DO, MPH, FACOG, and Mylynda Massart, MD, PhD, introduce this series on early cancer detection, multi-cancer detection tests, and the role of primary care physicians (PCPs) in preventative care.
Early Cancer Detection and the Role of PCPs
2 Clarke Drive Cranbury, NJ 08512